Perha Pharmaceuticals
PrivateLast Round
Grant
Mar 23, 2022
Company Overview
Perha Pharmaceuticals is a biotechnology company that develops small-molecule kinase inhibitors derived from natural marine products for the treatment of cognitive disorders and the prevention of hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perha Pharmaceuticals Comparables
Compare Perha Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmasum Therapeutics | 89% | |
| Iluminos Therapeutics LLC | 81% | |
| Connecta Therapeutics | 79% | |
Perha Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 23, 2022 | ||||
| VC Round | Mar 23, 2022 |
Perha Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2022
$6M round led by European Innovation Council Fund
Perha Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Perha Pharmaceuticals's valuation, stock price, and market status.